Periodontal disease is a chronic inflammatory disorder and being so it has been associated with accelerated atherosclerosis and malnutrition. Cardiovascular diseases are the leading cause of mortality in chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients [National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Annual Data Report, 2010]. A recent scientific statement released by the American Heart Association [Lockhart et al.: Circulation 2012;125:2520-2544] claims that, even though evidence exists to believe that periodontal interventions result in a reduction in systemic inflammation and endothelial dysfunction, there is little evidence that those interventions prevent atherosclerotic vascular disease or modify the outcomes. In this review, we discuss the periodontal findings and their association with an increased prevalence of inflammatory markers and cardiovascular mortality in ESRD patients and CKD.

Keywords:
Periodontitis, End-stage renal disease, Chronic kidney disease
1.
Annual Data Report: US Renal Data System. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.
2.
Lockhart PB, et al: Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart Association. Circulation 2012;125:2520-2544.
3.
Kho HS, et al: Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease undergoing hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:316-319.
4.
Kao CH, et al: Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis 2000;36:1110-1114.
5.
Bayraktar G, et al: Oral health and inflammation in patients with end-stage renal failure. Perit Dial Int 2009;29:472-479.
6.
Gay I, Viskoper JR, Chowers I: Maxillary tumour as a presenting sign of secondary hyperparathyroidism due to renal insufficiency. J Laryngol Otol 1971;85:737-742.
7.
Galili D, et al: The attitude of chronic hemodialysis patients toward dental treatment. Oral Surg Oral Med Oral Pathol 1983;56:602-604.
8.
Pihlstrom BL, Michalowicz BS, Johnson NW: Periodontal diseases. Lancet 2005;366:1809-1820.
9.
Oldenburg B, Macdonald GJ, Perkins RJ: Prediction of quality of life in a cohort of end-stage renal disease patients. J Clin Epidemiol 1988;41:555-564.
10.
Frankenthal S, et al: The effect of secondary hyperparathyroidism and hemodialysis therapy on alveolar bone and periodontium. J Clin Periodontol 2002;29:479-483.
11.
Martins C, et al: Salivary analysis of patients with chronic renal failure undergoing hemodialysis. Spec Care Dentist 2006;26:205-208.
12.
Chuang SF, et al: Oral and dental manifestations in diabetic and nondiabetic uremic patients receiving hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:689-695.
13.
Savica V, et al: Salivary phosphate secretion in chronic kidney disease. J Ren Nutr 2008;18:87-90.
14.
Tanner A, et al: Microbiota of health, gingivitis, and initial periodontitis. J Clin Periodontol 1998;25:85-98.
15.
Bragd L, et al: The capability of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius to indicate progressive periodontitis; a retrospective study. J Clin Periodontol 1987;14:95-99.
16.
Craig RG, et al: Serum IgG antibody response to periodontal pathogens in minority populations: relationship to periodontal disease status and progression. J Periodontal Res 2002;37:132-146.
17.
Lutfioglu M, et al: Dietary-induced hyperparathyroidism affects serum and gingival proinflammatory cytokine levels in rats. J Periodontol 2010;81:150-157.
18.
Gavalda C, et al: Renal hemodialysis patients: oral, salivary, dental and periodontal findings in 105 adult cases. Oral Dis 1999;5:299-302.
19.
Cengiz MI, et al: Does periodontal disease reflect atherosclerosis in continuous ambulatory peritoneal dialysis patients? J Periodontol 2007;78:1926-1934.
20.
Joseph R, Krishnan R, Narayan V: Higher prevalence of periodontal disease among patients with predialytic renal disease. Braz J Oral Sci 2009;8:14-18.
21.
Rahmati MA, et al: Serum markers of periodontal disease status and inflammation in hemodialysis patients. Am J Kidney Dis 2002;40:983-989.
22.
Fried L, et al: Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 2004;15:3184-3191.
23.
Chen LP, et al: Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients? Am J Kidney Dis 2006;47:815-822.
24.
Kadiroglu AK, et al: Periodontitis is an important and occult source of inflammation in hemodialysis patients. Blood Purif 2006;24:400-404.
25.
Kshirsagar AV, et al: Severe periodontitis is associated with low serum albumin among patients on maintenance hemodialysis therapy. Clin J Am Soc Nephrol 2007;2:239-244.
26.
Grubbs V, et al: Vulnerable populations and the association between periodontal and chronic kidney disease. Clin J Am Soc Nephrol 2011;6:711-717.
27.
Beck J, et al: Periodontal disease and cardiovascular disease. J Periodontol 1996;67(10 suppl):1123-1137.
28.
DeStefano F, et al: Dental disease and risk of coronary heart disease and mortality. BMJ 1993;306:688-691.
29.
Mattila KJ, et al: Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin Infect Dis 1995;20:588-592.
30.
Joshipura KJ, et al: Poor oral health and coronary heart disease. J Dent Res 1996;75:1631-1636.
31.
Morrison HI, Ellison LF, Taylor GW: Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk 1999;6:7-11.
32.
Hujoel PP, et al: Periodontal disease and coronary heart disease risk. JAMA 2000;284:1406-1410.
33.
Hung HC, et al: The association between tooth loss and coronary heart disease in men and women. J Public Health Dent 2004;64:209-215.
34.
Joshipura KJ, et al: Periodontal disease, tooth loss, and incidence of ischemic stroke. Stroke 2003;34:47-52.
35.
Tuominen R, et al: Oral health indicators poorly predict coronary heart disease deaths. J Dent Res 2003;82:713-718.
36.
Pussinen PJ, et al: High serum antibody levels to Porphyromonas gingivalis predict myocardial infarction. Eur J Cardiovasc Prev Rehabil 2004;11:408-411.
37.
Pussinen PJ, et al: Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol 2005;25:833-838.
38.
Kshirsagar AV, et al: Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney Int 2009;75:746-751.
39.
Bahekar AA, et al: The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007;154:830-837.
40.
Ziebolz D, et al: Oral health of hemodialysis patients: a cross-sectional study at two German dialysis centers. Hemodial Int 2012;16:69-75.
41.
Fisher MA, et al: Bidirectional relationship between chronic kidney and periodontal disease: a study using structural equation modeling. Kidney Int 2011;79:347-355.
42.
Taylor GW: Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol 2001;6:99-112.
43.
Paraskevas S, Huizinga JD, Loos BG: A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35:277-290.
44.
Dasanayake AP: C-reactive protein levels are elevated in patients with periodontitis and their CRP levels may go down after periodontal therapy. J Evid Based Dent Pract 2009;9:21-22.
45.
D'Aiuto F, et al: Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005;84:269-273.
46.
Elter JR, et al: The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J 2006;151:47.
47.
Mattila K, et al: Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis 2002;2:30.
48.
Taylor B, et al: The effect of initial treatment of periodontitis on systemic markers of inflammation and cardiovascular risk: a randomized controlled trial. Eur J Oral Sci 2010;118:350-356.
49.
Wehmeyer MM, et al: A randomized controlled trial of intensive periodontal therapy on metabolic and inflammatory markers in patients with ESRD: results of an exploratory study. Am J Kidney Dis 2013;61:450-458.
50.
Haffajee AD, Socransky SS, Gunsolley JC: Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003;8:115-181.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.